Crunching the numbers for BIOA... Refresh in a moment for the full analysis.
BioAge Labs, Inc. (BIOA)
Healthcare
mixed
$16.19
Updated: 2026-04-12
50
TradeApes Score
hold
Financial Strength
45
Mixed
Operating Trend
50
Mixed
Valuation
50
Mixed
Capital Allocation
40
Weak
Risk
80
Strong
Key Findings
+
Strong FCF growth — free cash flow up more than 20% year over year
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.